These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9190115)

  • 1. Immunoreceptor tyrosine-based inhibition motifs.
    Vivier E; Daëron M
    Immunol Today; 1997 Jun; 18(6):286-91. PubMed ID: 9190115
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells.
    Gergely J; Pecht I; Sármay G
    Immunol Lett; 1999 May; 68(1):3-15. PubMed ID: 10397150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts.
    Vély F; Vivier E
    J Immunol; 1997 Sep; 159(5):2075-7. PubMed ID: 9278290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of immunoreceptor tyrosine-based inhibition motif-bearing molecules.
    Daëron M; Vivier E
    Curr Top Microbiol Immunol; 1999; 244():1-12. PubMed ID: 10453645
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
    Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
    J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory ITAMs: a matter of life and death.
    Pinheiro da Silva F; Aloulou M; Benhamou M; Monteiro RC
    Trends Immunol; 2008 Aug; 29(8):366-73. PubMed ID: 18602341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of T cell activation.
    Saito T
    Curr Opin Immunol; 1998 Jun; 10(3):313-21. PubMed ID: 9638368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreceptor transmembrane peptides and their effect on natural killer (NK) cell cytotoxicity.
    Vandebona H; Ali M; Amon M; Bender V; Manolios N
    Protein Pept Lett; 2006; 13(10):1017-24. PubMed ID: 17168824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction.
    Pao LI; Famiglietti SJ; Cambier JC
    J Immunol; 1998 Apr; 160(7):3305-14. PubMed ID: 9531288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral immunoreceptor tyrosine-based activation motif (ITAM)-mediated signaling in cell transformation and cancer.
    Lanier LL
    Trends Cell Biol; 2006 Aug; 16(8):388-90. PubMed ID: 16815013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell signaling pathways.
    Vivier E; Nunès JA; Vély F
    Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
    Lanier LL; Corliss BC; Wu J; Leong C; Phillips JH
    Nature; 1998 Feb; 391(6668):703-7. PubMed ID: 9490415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
    Watanabe N; Gavrieli M; Sedy JR; Yang J; Fallarino F; Loftin SK; Hurchla MA; Zimmerman N; Sim J; Zang X; Murphy TL; Russell JH; Allison JP; Murphy KM
    Nat Immunol; 2003 Jul; 4(7):670-9. PubMed ID: 12796776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.
    Gavrieli M; Watanabe N; Loftin SK; Murphy TL; Murphy KM
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1236-43. PubMed ID: 14652006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function.
    Chen D; Iijima H; Nagaishi T; Nakajima A; Russell S; Raychowdhury R; Morales V; Rudd CE; Utku N; Blumberg RS
    J Immunol; 2004 Mar; 172(6):3535-43. PubMed ID: 15004154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCR engagement induces proline-rich tyrosine kinase-2 (Pyk2) translocation to the T cell-APC interface independently of Pyk2 activity and in an immunoreceptor tyrosine-based activation motif-mediated fashion.
    Sancho D; Montoya MC; Monjas A; Gordón-Alonso M; Katagiri T; Gil D; Tejedor R; Alarcón B; Sánchez-Madrid F
    J Immunol; 2002 Jul; 169(1):292-300. PubMed ID: 12077257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of anaphylactic inflammation by the gp49B1 receptor on mast cells.
    Katz HR
    Mol Immunol; 2002 Sep; 38(16-18):1301-5. PubMed ID: 12217399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic identification of immunoreceptor tyrosine-based inhibitory motifs in the human proteome.
    Staub E; Rosenthal A; Hinzmann B
    Cell Signal; 2004 Apr; 16(4):435-56. PubMed ID: 14709333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif.
    Kanazawa N; Okazaki T; Nishimura H; Tashiro K; Inaba K; Miyachi Y
    J Invest Dermatol; 2002 Feb; 118(2):261-6. PubMed ID: 11841542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.